Reference
Peptide stacks, researched honestly
A stack is a claim someone makes about combining compounds. These pages record who makes the claim, why, whether the combination itself has ever been studied, and where each component's evidence actually stops.
5 combinations in the file
- BPC-157 + TB-500Components indexed separately
Discussed as a pairing of two compounds with connective-tissue research histories — BPC-157 for tendon, ligament, gut and muscle models; TB-500 as a fragment of thymosin β4, whose full-length parent has wound-healing literature.
BPC-157 + TB-500 · Recovery
- CJC-1295 + IpamorelinComponents indexed separately
Discussed as a GHRH-analogue plus GH-secretagogue pairing intended to stimulate GH release through two pathways at once — the “synthetic GH axis” pairing.
CJC-1295 + Ipamorelin · Growth-hormone axis
- Cagrilintide + SemaglutideCombination registered as a trial
An investigational amylin analogue combined with an approved GLP-1 receptor agonist in a sponsor's Phase 3 programme for weight management — the rare pairing where the combination itself is genuinely under study..
Cagrilintide + Semaglutide · Metabolic
- Selank + SemaxCommunity-reported only
Two Russian-developed heptapeptides discussed together for cognition, anxiety and focus.
Selank + Semax · Cognitive
- GHK-Cu in cosmetic combinationsDiscussed in published sources
Copper tripeptide-1 appears in topical formulations alongside matrix-support ingredients (retinoids, niacinamide, other signal peptides).
GHK-Cu · Skin / cosmetic
The support label is the honest core of this library. Components indexed separately means Therapept indexes real evidence for each component but no study of the pairing itself — the default for community stacks. Combination registered as a trial means a registered trial tests the combination directly.
Compare the combinations side by side in the stack compare view.